Related Experiment Video
Updated: May 25, 2026

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
Published on: January 31, 2025
RACK1 promotes non-small-cell lung cancer tumorigenicity through activating sonic hedgehog signaling pathway
Shuo Shi1, Yue-Zhen Deng, Jiang-Sha Zhao
1Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences and Graduate School of Chinese Academy of Sciences, Shanghai 200031, China.
Abstract:
Non-small-cell lung cancer (NSCLC) is a deadly disease due to lack of effective diagnosis biomarker and therapeutic target. Much effort has been made in defining gene defects in NSCLC, but its full molecular pathogenesis remains unexplored. Here, we found RACK1 (receptor of activated kinase 1) was elevated in most NSCLC, and its expression level correlated with key pathological characteristics including tumor differentiation, stage, and metastasis. In addition, RACK1 activated sonic hedgehog signaling pathway by interacting with and activating Smoothened to mediate Gli1-dependent transcription in NSCLC cells. And silencing RACK1 dramatically inhibited in vivo tumor growth and metastasis by blocking the sonic hedgehog signaling pathway. These results suggest that RACK1 represents a new promising diagnosis biomarker and therapeutic target for NSCLC.
Insights
Receptor of activated kinase 1 (RACK1) is elevated in non-small-cell lung cancer (NSCLC) and promotes tumor growth and metastasis. Silencing RACK1 inhibits tumor progression, suggesting RACK1 as a potential biomarker and therapeutic target for NSCLC.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Non-small-cell lung cancer (NSCLC) lacks effective diagnostic biomarkers and therapeutic targets, hindering treatment efficacy.
- The complete molecular pathogenesis of NSCLC remains incompletely understood, necessitating further investigation into key molecular drivers.
Purpose of the Study:
- To investigate the role of Receptor of Activated Kinase 1 (RACK1) in the molecular pathogenesis of NSCLC.
- To evaluate RACK1 as a potential diagnostic biomarker and therapeutic target for NSCLC.
Main Methods:
- Expression analysis of RACK1 in NSCLC tissues.
- Correlation analysis between RACK1 expression and pathological characteristics.
- Investigation of RACK1's interaction with the sonic hedgehog signaling pathway components (Smoothened, Gli1).
- In vivo studies involving RACK1 silencing to assess tumor growth and metastasis.
Main Results:
- RACK1 expression was found to be elevated in most NSCLC cases.
- RACK1 expression levels correlated significantly with tumor differentiation, stage, and metastasis.
- RACK1 was shown to activate the sonic hedgehog signaling pathway by interacting with Smoothened, leading to Gli1-dependent transcription.
- Silencing RACK1 significantly inhibited in vivo tumor growth and metastasis by blocking the sonic hedgehog signaling pathway.
Conclusions:
- RACK1 plays a crucial role in promoting tumor growth and metastasis in NSCLC through the sonic hedgehog signaling pathway.
- RACK1 represents a promising novel diagnostic biomarker for NSCLC.
- RACK1 inhibition presents a potential therapeutic strategy for NSCLC treatment.
Related Concept Videos
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Induced Pluripotent Stem Cells
Somatic cells are...

